YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

TFX
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Bruker Gains 66.3% in a Year: What's Driving the Rally?

Bruker Corporation BRKR has witnessed strong momentum over the past year. Shares of the company have risen 66.3% compared with the industry's 66.4% growth. The S&P 500 composite has increased 18.2% during the same time frame. With healthy…

finance.yahoo.comPOSITIVO

Charles River Gains 75.8% in a Year: What's Driving the Rally?

Charles River Laboratories International CRL has witnessed strong momentum over the past year. Shares of the company have risen 75.8%, outperforming the industry's 10.5% growth. The S&P 500 composite has increased 16.1% during the same tim…

finance.yahoo.comPOSITIVO

Reasons to Add Globus Medical Stock to Your Portfolio Now

Globus Medical, Inc. GMED is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments. Also, product innovation and so…

finance.yahoo.comPOSITIVO

TFX or SONVY: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a clos…

finance.yahoo.comPOSITIVO

Is It Prudent to Add Teleflex Stock to Your Portfolio Now?

Teleflex's TFX Vascular business is well-positioned for growth in the upcoming quarters, led by sustained demand for central access and hemostatic products, coupled with new product introductions such as EZPLAZ. Further, the company's expa…

finance.yahoo.comPOSITIVO

3 Healthcare Stocks That Concern Us

3 Healthcare Stocks That Concern Us Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have r…

finance.yahoo.comPOSITIVO

Boston Scientific's MedSurg Diversification Bolsters Growth Prospects

Boston Scientific's BSX MedSurg segment continues to provide a diversified and stable revenue base. Within this, Endoscopy sales grew 7% year over year in the second quarter of 2026, driven by strong performance across the business and ano…

finance.yahoo.comPOSITIVO

Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex

Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex Check out the companies making headlines yesterday: PacBio (NASDAQ:PACB): Genomics company Pacific Biosciences of California (NASDAQ:PACB…

finance.yahoo.comPOSITIVO

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

Peer-reviewed publication in the American Journal of Infection Control demonstrates the use of CVCs protected with Arrowg+ard™ Technology are associated with a statistically significant and clinically meaningful reduction in the hazard of…

finance.yahoo.comPOSITIVO

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?

Teleflex TFX shares rallied 4.3% in the last trading session to close at $127.38. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.6% los…

finance.yahoo.comPOSITIVO

Should New Leadership And Debt Focus At Teleflex (TFX) Require Action From Investors?

Recently, Teleflex attracted attention as investors reacted to commentary that, despite weak constant-currency revenue growth and declining earnings metrics, some see the company as lagging broader market performance while others highlight…

finance.yahoo.comPOSITIVO

Why Teleflex (TFX) Stock Is Trading Up Today

Why Teleflex (TFX) Stock Is Trading Up Today What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.5% in the afternoon session after BofA Securities upgraded the stock from Neutral to Buy and raised its price tar…

finance.yahoo.comPOSITIVO

Nyxoah Appoints Liam Kelly as Chief Executive Officer

Nyxoah REGULATED INFORMATION INSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company's strategic U.S. presence and focus Mont-Saint-Guibert, Belgium – September 28, 2026, 10:30 pm CET / 4:…

finance.yahoo.comPOSITIVO

3 Reasons to Avoid TFX and 1 Stock to Buy Instead

3 Reasons to Avoid TFX and 1 Stock to Buy Instead Even though Teleflex (currently trading at $122.08 per share) has gained 6.2% over the last six months, it has lagged the S&P 500's 21.4% return during that period. This may have investors…

finance.yahoo.comPOSITIVO

Teleflex Growth Prospects, New Leadership Could Drive 2027 Re-Rating, BofA Securities Says

Teleflex (TFX) could be the next re-rating story, with its growth prospects, new leadership and pote PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…

finance.yahoo.comPOSITIVO

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well positioned for growth in the upcoming quarters, supported by continued test menu expansion. Meanwhile, strategic partnerships support assay development and create opportunities for recurring consumables revenues ac…

finance.yahoo.comPOSITIVO

Illumina Stock Surges 94.9% YTD: What's Behind the Rally?

Illumina ILMN shares have shown impressive momentum so far this year, surging 94.9%. The stock has outpaced the industry's 8.6% gain and the S&P 500 Composite's 13.1% rise. Carrying a Zacks Rank #3 (Hold) at present, the renowned genomics…

finance.yahoo.comPOSITIVO

Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now

Bio-Rad Laboratories, Inc. BIO is well poised to grow in the upcoming quarters, given the demand for its quality control and blood typing products in Clinical Diagnostics. In addition, growth across international markets boosts the stock's…

finance.yahoo.comPOSITIVO

Should You Continue to Hold IDXX Stock in Your Portfolio?

IDEXX Laboratories, Inc. IDXX is strengthening its Companion Animal Group ("CAG") business through recurring revenue growth, wider customer adoption and expanding diagnostic offerings. Software adoption continues to expand, with recurring…

finance.yahoo.comPOSITIVO

Is This the Right Time to Add DGX Stock to Your Portfolio?

Quest Diagnostics DGX is gaining momentum across physician, hospital and consumer channels, supported by customer wins, acquisitions and expanded offerings. The company's expanding advanced diagnostics portfolio is driving double-digit gro…

finance.yahoo.comPOSITIVO

Q2 Earnings Roundup: Intuitive Surgical (NASDAQ:ISRG) And The Rest Of The Surgical Equipment & Consumables - Specialty Segment

Q2 Earnings Roundup: Intuitive Surgical (NASDAQ:ISRG) And The Rest Of The Surgical Equipment & Consumables - Specialty Segment Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - spe…

finance.yahoo.comPOSITIVO

Teleflex (TFX) Adds A Board Veteran, Is The 19% Undervalued View Enough?

Teleflex board refresh puts governance in focus Teleflex (TFX) has added veteran medical device executive Sean M. Salmon to its Board of Directors. This appointment gives investors a fresh angle on the company's governance and its long ter…

finance.yahoo.comPOSITIVO

IDEXX Stock Gains Following the Acquisition of CoVet

IDEXX Laboratories, Inc. IDXX recently announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The acquisition of CoV…

finance.yahoo.comPOSITIVO

Reasons to Retain Penumbra Stock in Your Portfolio for Now

Penumbra, Inc.'s PEN robust product portfolio expansion is poised to drive growth in the upcoming quarters. The company's international expansion efforts are thriving. Unfavorable foreign exchange and a dull macroeconomic scenario may pose…

finance.yahoo.comPOSITIVO

Should Investors Add EYE Stock to Their Portfolios Now?

National Vision Holdings, Inc. EYE is seeing stronger customer spending and premium-product demand offset softer traffic, supporting its comparable-sales outlook. Steady vision-care needs and demand for value-priced eyewear provide a favor…

finance.yahoo.comPOSITIVO

Is This the Right Time to Retain Resmed Stock in Your Portfolio?

Resmed RMD benefits from the portfolio reduction of its Residential Care Software segment, which is poised to continue supporting its growth in the coming quarters. The company continues to expand its mask portfolio through product innovat…

finance.yahoo.comPOSITIVO

5 Low P/B Stocks That Offer Attractive Value and Growth

Price-to-earnings (P/E) and price-to-sales (P/S) are among the most commonly used valuation metrics for investors looking to narrow down a list of potentially undervalued stocks. However, the price-to-book (P/B) ratio, while often overlook…

finance.yahoo.comPOSITIVO

Should You Continue to Hold ALGN Stock in Your Portfolio?

Align Technology ALGN is well-positioned for growth in the upcoming quarters as it continues to broaden the clinical reach of the Invisalign portfolio beyond traditional adult and teen alignment. The company is focused on increasing adopti…

finance.yahoo.comPOSITIVO

TFX vs. PEN: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have fou…

finance.yahoo.comPOSITIVO

Q2 Earnings Outperformers: Integra LifeSciences (NASDAQ:IART) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Q2 Earnings Outperformers: Integra LifeSciences (NASDAQ:IART) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks Let's dig into the relative performance of Integra LifeSciences (NASDAQ:IART) and its peers as we unravel…

finance.yahoo.comPOSITIVO

Is This the Right Time to Add Neogen Stock to Your Portfolio?

Neogen Corporation NEOG is advancing its product development efforts across food and animal safety, supported by increased investment in innovation. The company is building on its 3M Food Safety combination to expand manufacturing capacity…

finance.yahoo.comPOSITIVO

Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines

Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines Looking back on surgical equipment & consumables - specialty stocks' Q2 earnings, we examine this quarter's best and worst performers, inclu…

finance.yahoo.comPOSITIVO

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

WAYNE, Pa., September 08, 2026--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026.…

finance.yahoo.comPOSITIVO

Should You Continue to Hold TMO Stock in Your Portfolio?

Thermo Fisher Scientific Inc.'s TMO growth continues to benefit from a broader pickup in customer activity. The company is using acquisitions to move deeper into some of the more attractive corners of the life sciences market while strengt…

finance.yahoo.comPOSITIVO

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

Results from previously presented BIONETIC-TRA study demonstrate the safety and feasibility of the device via trans-radial approach WAYNE, Pa., September 04, 2026--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provid…

finance.yahoo.comPOSITIVO

Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push

On August 6, Teleflex Incorporated (NYSE:TFX) reported second-quarter results for the period ended June 30, and the numbers told two different stories at once. Revenue from continuing operations climbed to $570.3 million, up 28.9% from a y…